[2] Wavex Corporation Announces Chris Evert Will Endorse And Play Wavex Racquets.

TORONTO--(BW SportsWire)--Nov. 11, 1999--

Wavex International Inc.'s subsidiary company, Wavex Corporation ("Wavex"), is pleased to announce today that they have entered into an agreement with Chris Evert to have her endorse and play Wavex tennis racquets for a three year term commencing January 1st, 2000. Additionally, Wavex further announces that it will manufacture and sell a series of "Wavex Chris Evert Autograph Racquets".

Chris Evert, one of the greatest tennis players in the history of the sport, was the first player to win 1,000 singles matches. During her 17-year professional career, she won 157 singles titles, 18 Grand Slam titles (3 Wimbledon's, 7 French Opens, 2 Australian Opens and 6 U.S. Opens). Evert won at least one Grand Slam singles title for 13 consecutive years (1974-1986), a record for men's and women's tennis. She was ranked #1 in the world for 7 years and when she was inducted into the International Tennis Hall of Fame on July 16, 1995, Evert was only the fourth player to be elected unanimously.

Since her retirement from professional tennis in 1989, Chris Evert has been a featured commentator for NBC-TV coverage of Wimbledon and the French Open. Additionally, as the founder of Chris Evert Charities, over the past ten years her efforts have raised over $7.3 million through the annual Chris Evert Pro-Celebrity Tennis Classic. Evert is also an active partner and coach at the Evert Tennis Academy ("ETA"), where Wavex enjoys its status of Official Tennis Racquet. Located in Boca Raton, Florida, the Evert Tennis Academy is a state of the art training facility specializing in the skill-development of young athletes from around the world. The innovative approach, which is being pursued by the Evert Tennis Academy in the development of its young athletes, is complemented by the WAVEX TECHNOLOGY( which is considered to be the next evolution in tennis racquets.

"Wavex has been a great supporter of my Academy and our pro staff over the past year," stated Evert. "In cultivating a relationship with Wavex through ETA, I became familiar with the technology and their racquets and I'm excited about my new relationship with this company."

Under the terms of the endorsement agreement with Wavex, Chris Evert will personally endorse and play Wavex racquets. She will also be instrumental in the design of the new millenium "Wavex Chris Evert Autograph Racquets".

"Last month, Wavex entered into an agreement with Jimmy Connors to endorse and play Wavex tennis racquets," stated Tom Larsen, CEO of Wavex. "With the addition of Chris Evert to the Wavex family, the company now is associated with two of the most recognizable names in the sport. This is a partnership that will certainly raise the profile of our product. The scheduled launch of both the Chris Evert and the Jimmy Connors Autograph Racquets in the year 2000 is a truly remarkable achievement for Wavex."

"It is a great privilege for Wavex to have Chris Evert and Jimmy Connors under the same racquet umbrella," stated David Brown, Director of Tennis for Wavex. "Chris and Jimmy bring a wealth of knowledge about the playing characteristics required for high performance tennis racquets which they will incorporate into their new millenium series of autograph racquets."

The High Performance, High Comfort qualities, which exist in Wavex tennis racquets, allow tennis players of all ages and all skill levels to maximize performance and minimize risk of injury to the wrist, elbow and shoulder. Wavex Corporation is a technology based company specializing in developing technically advanced sporting goods and industrial products incorporating its revolutionary WAVEX TECHNOLOGY(TM). Wavex's shares are publicly traded on the NQB Pink Sheets under the symbol WVXI.

This news release may contain forward-looking statements relating to the future performance of Wavex International Inc. ("Wavex"). Forward-looking statements, especially those concerning future performance, are subject to certain risks and uncertainties, and actual results may differ materially.